An oversubscribed private investment in public equity offering for shares of common stock (and/or pre-funded warrants to purchase shares of common stock) has been priced at $6.881 and stapled warrants to purchase shares of common stock with an exercise price of $10.134 per stapled warrant, according to Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company that focuses on providing a novel therapeutic neuromodulation approach for balance and gait deficits.